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INFORMED CONSENT: 
Outcomes of robotic-assisted laparoscopic 
prostatectomy versus open prostatectomy 
in surgical intervention of localized 
prostate cancer 
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ABSTRACT An informed consent conversation regarding robotic-assisted laparoscopic prostatectomy versus open 
prostatectomy in patients with localized prostate cancer. 
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Clinical Context 
Our patient is a 65-year-old man who presented to the urology clinic due to an elevated PSA of 7.7ng/mL. He has 
no significant medical history. A pelvic MRI revealed an intermediate risk lesion in the right mid gland of the 
prostate. Using the MRI images, a prostate biopsy was performed revealing grade group 2 prostate cancer 
(Gleason score 3+4). A repeat PSA had risen to 10.1ng/mL over a 2-month period. The patient presented to the 
clinic to discuss the results of the biopsy. Due to the grade group of the prostate cancer and the relatively long life 
expectancy of the patient, definitive intervention was recommended. Different possible modalities of treatment 
were discussed with the patient, including radiation therapy and cryoablation, but ultimately surgical intervention 
via radical prostatectomy was recommended. The patient asked for some time to digest his new diagnosis and to 
think about his options because the information was overwhelming, and he was concerned about urinary 
incontinence and erectile dysfunction.  
The patient returned to clinic three weeks after his biopsy review to discuss his thoughts on treatment. Together 
with the attending physician, the patient decided robotic-assisted laparoscopic prostatectomy would be the best 
option for him. However, he had some concerns about the robotic approach to the surgery and what that entailed. 
He stated, “I talked to a couple of my friends who were also diagnosed with prostate cancer and underwent open 
prostatectomies with good success. Why do you suggest a robotic surgery in comparison to an open procedure?” 
The patient’s question led the team to discuss the differences between a robotic-assisted laparoscopic 
prostatectomy (RALP) versus an open radical prostatectomy also known as retropubic radical prostatectomy (RRP). 
Clinical Question 
In patients with localized prostate cancer, does RALP provide improved outcomes compared to open prostatectomy? 
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Related Literature 
A literature review was performed by searching PubMed using the terms "robotic"[tiab] AND "open"[tiab] AND 
"prostatectomy"[tiab] AND "prostate cancer"[tiab] which yielded 334 search results. Within these results, several meta-analyses 
relevant to the clinical question were found. There is a lack of high quality randomized controlled trials to answer the clinical 
question. Therefore, observational studies were included in the literature review. While oncologic effect is the main indication for a 
radical prostatectomy, other parameters such as perioperative and functional outcomes were important to our patient and thus 
were considered during the literature review. Of the papers published in the last 10 years, eleven were determined to be of high 
quality and relevance in answering our clinical question. These articles each measured a combination of oncologic, functional, and 
perioperative outcomes of RALP versus RRP.  
Coughlin (2018)1 was the most recent randomized controlled trial published comparing RALP with RRP. A total of 326 men were 
enrolled in the study with strict exclusion criteria to only include men with localized prostate cancer. Patients were randomized to 
either RALP or RRP with data analysts and pathologists blinded to the treatment groups. Outcomes of oncologic results at 24 months 
post-procedure were evaluated. Oncologic outcomes at 6 and 12 months post-procedure were reported in an earlier publication.2 
Urinary incontinence and erectile dysfunction were assessed by validated scales.3,4 Urinary and sexual function assessed by 
questionnaire scores were not significantly different between RALP and RRP at any time point post-procedure. Oncologic outcomes, 
defined by biochemical recurrence with a PSA of 0.2ng/mL, were significantly better with RALP compared to RRP in this study. 
However, the authors state that oncologic management post-procedure of enrolled patients was not controlled and a higher 
number of RALP patients received adjunctive radiotherapy prior to any PSA increases that may have affected this finding. 
The next study was a retrospective cohort by Hu, et. al. in 2017.5 This was a study using a Medicare linked database. Two cohorts 
were propensity-matched and then compared; the first cohort having undergone RALP and the second having undergone an open 
prostatectomy. Both cohorts had the same risk of all-cause and cancer-specific mortality. Rates of complications were not 
investigated.  
The 2016 study by O’Neil, et. al. was another retrospective cohort study.6 It used two prospectively collected databases, which were 
collected almost two decades apart. Patients who had underwent RALP had improved sexual function at 6 and 12 months and 
improved urinary function at 6 months when compared to patients who underwent RRP. However, the improvement of urinary 
function was no longer present at 12 months.  
The last primary research discovered was Haglind et. al. in 2015.7 This was a prospective, multi-center study. In this observational 
study, patients undergoing RALP had less risk of erectile dysfunction at 12 months. There was no difference in urinary incontinence 
at 12 months.  
We also found several meta-analyses.8-18 None of these found any difference in mortality or other cancer-related outcomes between 
RALP and RRP. With regards to the complications of urinary incontinence and sexual dysfunction, results were mixed, with some 
analyses finding a modest benefit to robotic surgery, and some analyses finding no difference. The Cochrane analysis was the only 
analysis that looked exclusively at randomized trials and found no difference in either complication rate.12 
Overall, we found the literature supporting RALP to be lacking overall. Since most of the studies are cohort studies, they are at high 
risk of indication and recall bias. There is only one randomized control trial. Somewhat alarming was the amount of meta-analyses 
that have been performed; this can easily give the illusion that there is more and stronger evidence than there actually is. It was 
important for us to refocus on the primary literature to assess the strength of the literature overall.  
Even with this ambiguity in the literature, RALP has become the more popular surgical approach with an understanding that there is 
no strong evidence to suggest that it is superior in terms of oncologic or functional outcomes. 
Informed Consent 
Flesch-Kincaid Grade Level for the following passage is 5.8. 
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“We think we should take care of the cancer sooner rather than later. Your cancer is a medium grade and your PSA 
has risen. We think your cancer might spread. There are a few ways we could stop the cancer. We think surgery is 
the safe option for long term control of the cancer.  
“We like to recommend a robotic procedure for patients. You said that your friends also had this cancer but had an 
open surgery. I will explain what is different between the two types.   
“I went through the studies over the last 10 years to find an answer to your question. Unfortunately, it is still 
unclear which surgery is better. Also, the quality of the studies was not the best. What most studies found was that 
one type of surgery is not better than the other to stop the cancer. Both types have good cure rates in cancer 
similar to yours.  
“Since this is a big surgery, there are some complications that we can’t stop. These include bladder and sexual 
problems. For healthy people like you, these problems usually improve over time. Some studies show improved 
sexual function with robotic surgery. However, the best study did not. No studies showed long-term differences in 
bladder problems.  
“The main benefit of the robotic surgery is in the short term. Most studies show that there was less bleeding and 
fewer blood transfusions with the robot. Also, patients usually go home in a day or two. The open surgery patients 
usually stay in the hospital longer. Due to these factors, we think that the robotic surgery may be the better 
option. 
“Overall, both procedures do a great job to stop the cancer. There is not much high-quality data showing that one 
is better than the other. Most people think that the robot is better in the short term. Our group is most 
experienced with robotic surgery. That is why we would recommend this surgery to you. I would like to know what 
you think so we can decide together what the best option would be for you.” 
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